Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver

Nanox’s HealthFLD is pioneering the use of a fully automated AI software for liver attenuation analysis from CT scans that has received FDA 510 clearance for use in general population Expands...

Related Keywords

United States ,Israel ,American ,Mike Cavanaugh ,Erez Meltzer ,Perryj Pickhardt ,Clin Gastroenterol Hepatol ,Ben Shannon ,Nanox Health ,Nasdaq ,Exchange Commission ,Holdings Inc ,Drug Administration ,Nanox Ai Ltd ,Chief Executive Officer ,American Journal ,Wisconsin School ,Public Health ,Digital Tomosynthesis ,Private Securities Litigation Reform Act ,Nanox System ,Forward Looking Statements ,Annual Report ,Moderate Hepatic Steatosis ,Portal Venous Phase Contrast Enhanced ,Evaluation Using ,Automated Artificial Intelligence ,Amer Jour Roentgen ,Markets ,